Bactericidal debridement compositions for surgical site infections and chronic wound healing
US11826333B2 · kind B2 · utility
0Cited by
9References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2021 |
| Grant date | Nov 28, 2023 |
| Priority date | — |
| Expiry date | May 23, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions for treating biofilm-derived infections include a cis-monounsaturated fatty acid solubilized in a solvent with a concentration in the range of about 100 ppm (parts per million) to about 1000 ppm, where the composition is configured to produce a bactericidal effect measured as a log reduction of colony forming units (CFU) of a bacteria of at least 1.0 when the composition is applied to a biofilm formed from the bacteria. Also provided are methods for treating the site of a biofilm-derived infection comprising applying a composition as disclosed herein to the site.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.